Stereotactic body radiation therapy for centrally located hepatocellular carcinoma: outcomes and toxicities
ConclusionsIn the present cohort, SBRT to the CL-HCC produced excellent treatment response with acceptable HBT and LC. Select HCC patients who are not candidates for surgery or other locoregional therapies can be considered for SBRT to the central liver.
Source: Journal of Cancer Research and Clinical Oncology - Category: Cancer & Oncology Source Type: research
More News: Bilirubin | Cancer | Cancer & Oncology | Carcinoma | Children | Hepatocellular Carcinoma | Liver | Liver Cancer | Radiation Therapy | Toxicology | Urology & Nephrology